Classification of solid renal tumor with oncocytic/eosinophilic cytoplasm: is hybrid oncocytic/chromophobe renal tumor a subtype of oncocytoma, chromophobe renal cell carcinoma, or a distinct tumor entity?

Classification of solid renal tumor with oncocytic/eosinophilic cytoplasm: is hybrid oncocytic/chromophobe renal tumor a subtype of oncocytoma, chromophobe renal cell carcinoma, or a distinct tumor entity?
复制标题

DOI:
10.21037/atm.2019.09.77
复制
发表时间:
2019-09
影响因子:
--
通讯作者:
S. Mikami;N. Kuroda;Y. Nagashima;C. Ohe;H. Hayashi;R. Mizuno;M. Oya;K. Kameyama
S. Mikami;N. Kuroda;Y. Nagashima;C. Ohe;H. Hayashi;R. Mizuno;M. Oya;K. Kameyama
中科院分区:
医学4区
文献类型:
--
作者:
S. Mikami;N. Kuroda;Y. Nagashima;C. Ohe;H. Hayashi;R. Mizuno;M. Oya;K. Kameyama

文献摘要

相似文献

肾嗜酸细胞瘤的病理诊断通常较困难,其鉴别诊断涉及肾嫌色细胞癌(ChRCC)、肾嗜酸细胞瘤(RO)、肾透明细胞癌(CCRCC)、上皮样血管平滑肌脂肪瘤(EAML)等。肾嗜酸细胞/嫌色细胞混合瘤(HOCT)是一种新出现的实体,WHO泌尿系统分类中没有HOCT的描述,第三版(1)。
Pathological diagnosis of oncocytic renal tumor is usually difficult task, and their differential diagnosis involves chromophobe renal cell carcinoma (ChRCC), renal oncocytoma (RO), clear cell renal cell carcinoma (CCRCC), epithelioid angiomyolipoma (EAML), etc. Hybrid oncocytic/chromophobe tumor (HOCT) of the kidney is an emerging entity, and there is no description on HOCT in the WHO classification of the urinary system, third edition (1).